Skip to content
In conversation with... Changsong Qi episode artwork

Jun 1, 2025 14 min

In conversation with... Changsong Qi

from Listen to The Lancet Hosted by The Lancet

Changsong Qi joins Chloe Wilson and Ben Abbott of The Lancet to discuss their recently published phase 2 randomised controlled trial investigating Claudin-18 isoform 2-specific CAR T-cell therapy for previously treated advanced gastric or gastro-oesophageal junction cancer.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

In conversation with... Changsong Qi

0:00 14:45

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Listen to The Lancet?

This episode is 14 minutes long.

When was this Listen to The Lancet episode published?

This episode was published on June 1, 2025.

Can I download this Listen to The Lancet episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.